Literature DB >> 22917472

3D-QSAR based on quantum-chemical molecular fields: toward an improved description of halogen interactions.

Stefan Güssregen1, Hans Matter, Gerhard Hessler, Marco Müller, Friedemann Schmidt, Timothy Clark.   

Abstract

Current 3D-QSAR methods such as CoMFA or CoMSIA make use of classical force-field approaches for calculating molecular fields. Thus, they can not adequately account for noncovalent interactions involving halogen atoms like halogen bonds or halogen-π interactions. These deficiencies in the underlying force fields result from the lack of treatment of the anisotropy of the electron density distribution of those atoms, known as the "σ-hole", although recent developments have begun to take specific interactions such as halogen bonding into account. We have now replaced classical force field derived molecular fields by local properties such as the local ionization energy, local electron affinity, or local polarizability, calculated using quantum-mechanical (QM) techniques that do not suffer from the above limitation for 3D-QSAR. We first investigate the characteristics of QM-based local property fields to show that they are suitable for statistical analyses after suitable pretreatment. We then analyze these property fields with partial least-squares (PLS) regression to predict biological affinities of two data sets comprising factor Xa and GABA-A/benzodiazepine receptor ligands. While the resulting models perform equally well or even slightly better in terms of consistency and predictivity than the classical CoMFA fields, the most important aspect of these augmented field-types is that the chemical interpretation of resulting QM-based property field models reveals unique SAR trends driven by electrostatic and polarizability effects, which cannot be extracted directly from CoMFA electrostatic maps. Within the factor Xa set, the interaction of chlorine and bromine atoms with a tyrosine side chain in the protease S1 pocket are correctly predicted. Within the GABA-A/benzodiazepine ligand data set, PLS models of high predictivity resulted for our QM-based property fields, providing novel insights into key features of the SAR for two receptor subtypes and cross-receptor selectivity of the ligands. The detailed interpretation of regression models derived using improved QM-derived property fields thus provides a significant advantage by revealing chemically meaningful correlations with biological activity and helps in understanding novel structure-activity relationship features. This will allow such knowledge to be used to design novel molecules on the basis of interactions additional to steric and hydrogen-bonding features.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22917472     DOI: 10.1021/ci300253z

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  4 in total

Review 1.  Semiempirical Quantum Mechanical Methods for Noncovalent Interactions for Chemical and Biochemical Applications.

Authors:  Anders S Christensen; Tomáš Kubař; Qiang Cui; Marcus Elstner
Journal:  Chem Rev       Date:  2016-04-13       Impact factor: 60.622

2.  EMPIRE: a highly parallel semiempirical molecular orbital program: 2: periodic boundary conditions.

Authors:  Johannes T Margraf; Matthias Hennemann; Bernd Meyer; Timothy Clark
Journal:  J Mol Model       Date:  2015-05-17       Impact factor: 1.810

3.  Quantum Artificial Neural Network Approach to Derive a Highly Predictive 3D-QSAR Model for Blood-Brain Barrier Passage.

Authors:  Taeho Kim; Byoung Hoon You; Songhee Han; Ho Chul Shin; Kee-Choo Chung; Hwangseo Park
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

4.  Quantum-mechanical property prediction of solvated drug molecules: what have we learned from a decade of SAMPL blind prediction challenges?

Authors:  Nicolas Tielker; Lukas Eberlein; Gerhard Hessler; K Friedemann Schmidt; Stefan Güssregen; Stefan M Kast
Journal:  J Comput Aided Mol Des       Date:  2020-10-20       Impact factor: 3.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.